Industry News
Breast cancer spread: clues found in molecular switch
Sep 30, 2013
Using state of the art technology, researchers at the University of Copenhagen in Denmark have pinpointed molecular mechanisms that they suspect play an important role in breast cancer cell growth and spread (metastasis)... Read More
Commercial urine test for prostate cancer available
Sep 30, 2013
A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs... Read More
Novel tool developed by colorectal surgeons for measuring quality and outcomes
Sep 30, 2013
Since the publication in 2000 of a report titled "To Err is Human" by the Institute of Medicine which called for a reduction in preventable medical errors, there has been an increasing demand for making improvements in the quality and measurement of health care outcomes... Read More
LEO Pharma announce the completion of the Phase III FIELD Study 1, evaluating one year treatment outcomes of actinic keratosis
Sep 30, 2013
LEO Pharma has announced the completion of the Phase III FIELD Study 1 - the largest[1-3] ever, one year evaluation of field treatment with ingenol mebutate gel for actinic keratosis (AK) after initial cryosurgery of individual AK lesions, compared to cryosurgery followed by a vehicle gel... Read More
esperityTM: the first multi-lingual online community for cancer patients worldwide
Sep 30, 2013
esperityTM (www.esperity.com) announces its going live as the first multi-lingual social media network dedicated exclusively to cancer patients. esperityTM aims to support cancer patients around the world by providing them with an online environment where they can connect with each other and share information, thereby reducing the feeling of isolation many experience while dealing with cancer... Read More
Commercial urine test for prostate cancer available
Sep 30, 2013
A new urine test for prostate cancer that measures minute fragments of RNA is now commercially available to men nationwide through the University of Michigan MLabs... Read More
Novel tool developed by colorectal surgeons for measuring quality and outcomes
Sep 30, 2013
Since the publication in 2000 of a report titled "To Err is Human" by the Institute of Medicine which called for a reduction in preventable medical errors, there has been an increasing demand for making improvements in the quality and measurement of health care outcomes... Read More
The immunological function of mucus
Sep 30, 2013
Researchers at Institut Hospital del Mar d'Investigacions Mediques (IMIM) in Barcelona, in collaboration with the Icahn School of Medicine at Mount Sinai in New York and other U.S. Institutions, have found that intestinal mucus not only acts as a physical barrier against commensal bacteria and dietary antigens, but also prevents the onset of inflammatory reactions against these agents... Read More
Zebrafish embryo's cells can move in one direction by creating their own gradient: Study has possible implications for cancer and metastasis
Sep 30, 2013
Migrating cells, it seems, cover their tracks not for fear of being followed, but to keep moving forward. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have now shown that cells in a zebrafish embryo determine which direction they move in by effectively erasing the path behind them... Read More
Common patterns shared by different tumor types suggest new cancer treatment options
Sep 30, 2013
Cancer encompasses a complex group of diseases traditionally defined by where in the body it originates, as in lung cancer or colon cancer. This framework for studying and treating cancer has made sense for generations, but molecular analysis now shows that cancers of different organs have many shared features, while cancers from the same organ or tissue are often quite distinct... Read More
Previous Page Next Page